Testicular cancer is the most common type of cancer to affect men between the ages of 15 and 49, and around 95% of these cases are caused by testicular germ cell tumors. Although testicular germ cell tumors typically manifest ...
Apr 28, 2021
0
2
Modified immune cells that ruthlessly kill cancerous tumors may prove a game-changer for people living with late-stage cancer.
Apr 15, 2021
0
262
Despite surgery and subsequent treatment with chemotherapy and radiation, the majority of patients experience recurrence of malignant brain tumors. Researchers at Linköping University, Sweden, and the Medical University ...
Apr 15, 2021
0
1
Using samples of small cell lung tumors, a research team led by biologist Dr. Silvia von Karstedt has discovered two new ways to induce tumor cell death. One of two subsets of tumor cells can be targeted by activating ferroptosis: ...
Apr 6, 2021
0
75
The standard treatment for advanced metastatic prostate cancer (PCa) is androgen deprivation therapy (ADT). And even if this is efficient in the short term, 1/3 of PCa will become resistant to ADT and develop castration-resistant ...
Mar 29, 2021
0
88
A team of researchers has studied the molecular profile of small "messenger" vesicles called exosomes, produced by cancer stem cells (CSCs), which play a key role in the process of carcinogenesis and metastasis in the blood ...
Mar 25, 2021
0
3
Traits that allow cancer cells to escape the body's natural defense system and develop into tumors are actually a good indicator to a patient's survival prognosis, according to University of Queensland researchers.
Mar 24, 2021
0
28
Breast cancer is the most common type of tumor found in women. Each year in Germany alone, 69,000 new cases are diagnosed. Around 80 percent of tumors originate in the luminal cells, the milk-producing cells of the mammary ...
Mar 22, 2021
0
104
In cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.
Mar 18, 2021
0
42
The Telomeres and Telomerase Group led by Maria A. Blasco at the Spanish National Cancer Research Centre (CNIO) continues to make progress in unraveling the role that telomeres—the ends of chromosomes that are responsible ...
Mar 10, 2021
0
4
